Health economics and financing

著者

書誌事項

Health economics and financing

Thomas E. Getzen

Wiley, c2007

3rd ed

  • : hbk

大学図書館所蔵 件 / 全3件

この図書・雑誌をさがす

注記

Includes bibliographical references and index

内容説明・目次

目次

Preface. Acknowledgments. About the Author. Foreword. 1 Terms of Trade: The Flow of Funds Through the Health Care System. 1.1 WHAT IS ECONOMICS? 1.2 THE FLOWOF FUNDS. 1.3 QUALITY. 1.4 PUBLIC OR PRIVATE CHOICES. 1.5 RESEARCH. 1.6 TIME. 1.7 ECONOMIC PRINCIPLES AS CONCEPTUAL TOOLS. 1.8 HEALTH PRINCIPLES. 1.9 HEALTH AND THE ECONOMY. 2 Demand and Supply. 2.1 NEED VERSUS DEMAND. 2.2 THE DEMAND CURVE. 2.3 MARGINAL REVENUE. 2.4 IS MONEY THE ONLY PRICE? 2.5 SUPPLY: INPUTS AND PRODUCTION FUNCTIONS. 2.6 MARKETS. 2.7 THE PRODUCTION OF HEALTH. 2.8 EFFICIENCY. 3 Cost-Benefit and Cost-Effectiveness Analysis. 3.1 COST-BENEFIT ANALYSIS IS ABOUT MAKING CHOICES. 3.2 MAXIMIZATION: FINDING THE OPTIMUM. 3.3 MEASURING BENEFITS. 3.4 MEASURING COSTS. 3.5 EVIDENCE-BASED MEDICINE. 3.6 THE VALUE OF LIFE. 3.7 QUALITY-ADJUSTED LIFE YEARS (QALYs). 3.8 PERSPECTIVES: PATIENT, PAYER, GOVERNMENT, PROVIDER, SOCIETY. 4 Health Insurance: Financing Medical Care. 4.1 METHODS FOR COVERING RISKS. 4.2 INSURANCE: THIRD-PARTY PAYMENT. 4.3 RISK AVERSION. 4.4 ADVERSE SELECTION. 4.5 MORAL HAZARD. 4.6 TAX BENEFITS. 4.7 EFFECTS OF HEALTH INSURANCE ON LABOR MARKETS. 4.8 HISTORY OF HEALTH INSURANCE. 4.9 FINANCING HEALTH CARE: INSURANCE AS A FUNDING MECHANISM. 5 Insurance Contracts and Managed Care. 5.1 TYPES OF INSURANCE PLANS. 5.2 HSA's, MEDICAL SAVINGS ACCOUNTS AND "CONSUMER-DRIVEN HEALTH PLANS." 5.3 A RANGE OF RISK BEARING: FIXED PREMIUMS, ADMINISTERED SERVICES ONLY, AND SELF-INSURANCE. 5.4 MANAGED CARE PLANS. 5.5 THE RANGE OF MANAGED CARE PLANS. 5.6 IS MANAGED CARE THE SOLUTION TO RISING COSTS? 5.7 MANAGED COMPETITION: THE ENTHOVEN PLAN. 5.8 INCENTIVES-TO PATIENTS, TO PAYERS, AND TO PROVIDERS. 6 Physicians. 6.1 FINANCING PHYSICIAN SERVICES: REVENUES. 6.2 PHYSICIAN INCOMES. 6.3 PHYSICIAN FINANCING: EXPENSES. 6.4 THE TRANSACTION BETWEEN DOCTOR AND PATIENT. 6.5 UNCERTAINTY. 6.6 LICENSURE: QUALITY OR PROFITS? 7 Medical Education, Organization, and Business Practices. 7.1 MEDICAL EDUCATION. 7.2 THE ORIGINS OF LICENSURE AND LINKAGE TO MEDICAL EDUCATION. 7.3 ADJUSTING PHYSICIAN SUPPLY. 7.4 GROUP PRACTICE: HOWORGANIZATION AND TECHNOLOGY AFFECT TRANSACTIONS. 7.5 KICKBACKS, SELF-DEALING, AND SIDE PAYMENTS. 7.6 PRICE DISCRIMINATION. 7.7 PRACTICE VARIATIONS. 7.8 INSURANCE, PRICE COMPETITION, AND THE STRUCTURE OF MEDICAL MARKETS. 8 Hospitals. 8.1 FROMCHARITABLE INSTITUTIONS TO CORPORATE CHAINS: DEVELOPMENT OF THE MODERN HOSPITAL. 8.2 HOSPITAL FINANCING: REVENUES. 8.3 HOSPITAL FINANCING: EXPENSES. 8.4 FINANCIAL MANAGEMENT AND COST SHIFTING. 8.5 HOWDO HOSPITALS COMPETE? 8.6 ORGANIZATION:WHOCONTROLS THE HOSPITAL AND FOR WHAT ENDS? 9 Management and Regulation of Hospital Costs. 9.1 WHY DO SOME HOSPITALS COST MORE THAN OTHERS? 9.2 HOWMANAGEMENT CONTROLS COSTS. 9.3 CONFLICT BETWEEN ECONOMIC THEORY AND ACCOUNTING MEASURES OF PER UNIT COST. 9.4 ECONOMIES OF SCALE. 9.5 QUALITY AND COST. 9.6 CONTROLLING HOSPITAL COSTS THROUGH REGULATION. 10 Long-Term Care. 10.1 DEVELOPMENT OF THE LONG-TERM CARE MARKET. 10.2 DEFINING LTC: TYPES OF CARE. 10.3 MEDICAID: NURSING HOMES AS A TWO-PART MARKET. 10.4 CERTIFICATE OF NEED: WHOSE NEEDS? 10.5 CASE-MIX REIMBURSEMENT. 10.6 SUBSTITUTION. 10.7 FINANCIAL REIMBURSEMENT CYCLES. 10.8 CONTINUING CARE RETIREMENT COMMUNITIES AND THE WEALTHY ELDERLY. 10.9 THE EFFECTS OF AGING ON COST AND UTILIZATION. 11 Pharmaceuticals. 11.1 PHARMACEUTICAL REVENUES: SOURCES OF FINANCING. 11.2 USES OF FUNDS. 11.3 HISTORY AND REGULATION OF PHARMACEUTICALS. 11.4 RESEARCH AND DEVELOPMENT. 11.5 PHARMACOECONOMICS AND OUTCOMES RESEARCH. 11.6 INDUSTRY STRUCTURE AND COMPETITION. 11.7 TRENDS: FORM FOLLOWS FUNCTION (AND MONEY). 12 Capital Financing And Ownership of Health Care Providers. 12.1 WHAT IS CAPITAL FINANCING? 12.2 VALUE AND RATE OF RETURN. 12.3 UNCORRELATED (INDEPENDENT) AND CORRELATED (SYSTEM) RISKS. 12.4 OWNERSHIP AND AGENCY. 12.5 CAPITAL FINANCING: HOSPITALS. 12.6 WORKING CAPITAL AND THE CASH FLOWCYCLE. 12.7 HMO OWNERSHIP AND CAPITAL MARKETS: SIGNS OF FAILURE. 13 Macroeconomics of Medical Care. 13.1 WHAT ISMACRO? 13.2 THE CONSUMPTION FUNCTION. 13.3 ADJUSTING TO CHANGE: DYNAMICS. 13.4 FORECASTING FUTURE HEALTH EXPENDITURES. 13.5 COST CONTROLS: SPENDING GAPS AND THE PUSH TO REGULATE. 13.6 WORKFORCE DYNAMICS: "SPENDING" IS MOSTLY LABOR. 14 The Role of Government. 14.1 GOVERNMENT HEALTH FINANCING. 14.2 THE ROLES OF GOVERNMENT. 14.3 LAWAND ORDER. 14.4 PUBLIC GOODS AND EXTERNALITIES. 14.5 MARKET FAILURE. 14.6 INCOME REDISTRIBUTION AND CARE OF THE POOR. 14.7 HOWGOVERNMENTWORKS. 14.8 PROS AND CONS OF REGULATION AND COMPETITION. 15 Public Goods and Public Health. 15.1 CHARACTERISTICS OF PUBLIC GOODS. 15.2 INFORMATION. 15.3 THE THEORY OF PURE PUBLIC GOODS. 15.4 INFECTIOUS DISEASE EXTERNALITIES. 15.5 SEX, DRUGS, ANDWAR: PUBLIC HEALTH IN ACTION. 16 History, Demography, and the Growth of Modern Medicine. 16.1 ECONOMIC GROWTH HAS DETERMINED THE SHAPE OF HEALTH CARE. 16.2 BIRTH RATES, DEATH RATES, AND POPULATION GROWTH. 16.3 THE STONE AGE. 16.4 THE AGRICULTURAL AGE. 16.5 THE INDUSTRIAL AGE. 16.6 THE INFORMATION AGE. 16.7 INCOME AND HEALTH. 16.8 REDUCING UNCERTAINTY: THE VALUE OF LIFE AND ECONOMIC SECURITY. 16.9 THE RISE OF MEDICAL TECHNOLOGY. 17 International Comparisons of Health and Health Expenditures. 17.1 WIDE DIFFERENCES AMONG NATIONS. 17.2 MICRO VERSUS MACRO ALLOCATION: HEALTH AS A NATIONAL LUXURY GOOD. 17.3 CAUSALITY: DOES MORE SPENDING IMPROVE HEALTH? 17.4 LOW-INCOME COUNTRIES. 17.5 MIDDLE-INCOME COUNTRIES. 17.6 HIGH-INCOME COUNTRIES. 17.7 INTERNATIONAL TRADE IN HEALTH CARE. 18 Value for Money in the Future of Health Care. 18.1 FORCING THE QUESTION:WHOGETS HEALTHY ANDWHO GETS PAID? 18.2 SPENDING MONEY OR PRODUCING HEALTH? 18.3 ALLOCATION, ALLOCATION, ALLOCATION. 18.4 DYNAMIC EFFICIENCY. 18.5 THE FUTURE. Glossary. Index.

「Nielsen BookData」 より

詳細情報

ページトップへ